ClinicalTrials.gg
Drug

Ticagrelor clinical trials

Also written Brilinta, Brilique and AZD6140.

studies test it
296
open now
29
in phase 3
75
first study started
2006

How each study uses Ticagrelor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ticagrelor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Jul 2011 · BRILINTA · NDA 022433 (FDA, Drugs@FDA)
European Union
3 Dec 2010 · Brilique · EMEA/H/C/001241 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ticagrelor
190
Ticagrelor 90mg
16
Ticagrelor 90 MG
16
group A
9
Ticagrelor 60mg
8

Brand

Brilinta
76
Brilique
30
Possia
4
Brilinta 45 mg
2
Brilique 60 mg
1
Brilinta 90 mg
1
Brilinta 180 mg
1
Brilinta 60 mg
1

Development codes

AZD6140
10
SUB30898
1

In one entry with another drug

Given together, or one or the other

Aspirin + Ticagrelor
3
Ticagrelor + Aspirin
2
Ticagrelor and Aspirin
2
Ticagrelor and Acetylsalicylic acid
2

Studies by the year they started

295 studies that test it; most in 2014 (52); 1 more planned to start later

Studies that test Ticagrelor, by start year
YearStudies
20061
20072
20084
20091
20103
20117
201226
201330
201452
201542
201618
201720
201818
201912
20209
202112
202211
20238
202413
20251
20265

Who runs them

Industry 46 · Other 250

AstraZeneca (40) · University of Florida (14) · University of Patras (12) · Kafrelsheikh University (10) · First Affiliated Hospital of Harbin Medical University (9) · Collegium Medicum w Bydgoszczy (5) · Dong-A University (5) · Ottawa Heart Institute Research Corporation (4)

Often tested with

Tested in the same studies.

Clopidogrel (52) · Aspirin (32) · Prasugrel (31) · Rivaroxaban (6) · Cilostazol (6) · Rosuvastatin (3) · Eptifibatide (2) · Dabigatran (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7, 3 in phase 3

Studies that test Ticagrelor, phase 3 first.

Studies

Open first, then newest update. How each study uses Ticagrelor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 296

See all 296 studies that test Ticagrelor →

Given beside what is tested · 30 — Ticagrelor is usual care or a partner of the new treatment

Showing 20 of 30.

As the comparator · 16 — what is tested is compared with Ticagrelor

Codes

What other systems call Ticagrelor · ClinicalTrials.gg INT006735

  • MeSH (NLM) D000077486TicagrelorConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) GLH0314RVCTICAGRELORConfirmed FDA, NLM, Wikidata
  • RxNorm 1116632Confirmed FDA, Wikidata
  • Wikidata Q420542ticagrelorConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C76404TicagrelorOne source FDA
  • DrugBank DB08816One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.